TCS 2314 (compound 3) 是具有口服活性和选择性的甚晚期抗原 4 (VLA-4, α4β1, CD49d/CD29) 拮抗剂，IC50 为 4.4 nM。
| Cas No. | 317353-73-4 |
| 化学名 | (S,Z)-2-(1-(4-(2-(4-((hydroxy(o-tolylimino)methyl)amino)phenyl)acetyl)morpholine-3-carbonyl)piperidin-4-yl)acetic acid |
| Canonical SMILES | CC1=CC=CC=C1/N=C(O)/NC2=CC=C(CC(N3CCOC[C@@]3([H])C(N4CCC(CC(O)=O)CC4)=O)=O)C=C2 |
| 分子式 | C28H34N4O6 |
| 分子量 | 522.59 |
| 溶解度 | <52.26mg/ml in DMSO;<26.13mg/ml in ethanol |
| 储存条件 | Store at RT |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | TCS 2314 (compound 3) is orally active and selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM[1]. References:
[1]. Muro F, et al. Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist. J Med Chem. 2009 Dec 24;52(24):7974-92. |
